Meta-analysis of association between ApoE ε4 allele and schizophrenia

Schizophrenia Research

Volumn 84, Issue 2-3, 2006, Pages 228-235

  Xu, Ming Qing ^a,b   St Clair, David ^c   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apolipoprotein E gene; Association; Meta analysis; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALE; META ANALYSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; RISK FACTORS; SCHIZOPHRENIA;

EID: 33646534632     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.02.015     Document Type: Article

References (55)

1. Arnold S.E., Joo E., Martinoli M.G., Roy N., Trojanowski J.Q., and Gur R.E. Apolipoprotein E genotype in schizophrenia, frequency, age at onset, and neuropathological features. NeuroReport 8 (1997) 1523-1526
2. Benjamin R., Leake A., Edwardson J.A., McKeith I.G., Ince P.G., and Perry R.H. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 343 (1994) 1565
3. Borecki I.B., and Suarez B.K. Linkage and association, basic concepts. Adv. Genet. 42 (2001) 45-66
4. Chen J., Hong C.J., Chiu H.J., Lin C.Y., Bai Y.M., and Song H.L. Apolipoprotein E genotype and schizophrenia. Biol. Psychiatry 39 (1999) 141-143
5. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., and Small G.W. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
6. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., and Gaskell P.C. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7 (1994) 180-184
7. Das H.K., McPherson J., Brun G.A.P., Karathanasis S.K., and Breslow J.L. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260 (1985) 6240-6247
8. Dean B., Laws S.M., Hone E., Taddei K., Scarr E., and Thomas E.A. Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biol. Psychiatry 54 (2003) 616-622
9. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
10. Digney A., Keriakous D., Scarr E., Thomas E., and Dean B. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder. Biol. Psychiatry 7 (2005) 711-715
11. Durany N., Riederer P., and Cruz-Sanchez F.F. Apolipoprotein E genotype in Spanish schizophrenic patients. Psychiatr. Genet. 10 (2000) 73-77
12. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315 (1997) 629-634
13. Fan, J.B., Sklar, P., 2005. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol. Psychiatry, 10, 928-38, 891.
14. Faraone S.V., Doyle A.E., Mick E., and Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit. Am. J. Psychiatry 158 (2001) 1052-1057
15. Fernandez T., Yan W.L., Hamburger S., Rapoport J.L., Saunders A.M., and Schapiro M. Apolipoprotein E alleles in childhood-onset schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88 (1999) 211-213
16. Frisoni G.B., Calabresi L., Geroldi C., Bianchetti A., D'Acquarica A.L., and Govoni S. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 5 (1994) 240-242
17. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia, meta-analysis of case-control and family-based studies. Am. J. Psychiatry 160 (2003) 469-476
18. Gottesman I.I. Schizophrenia Genesis: The Origins of Madness (1999), W H Freeman and Co, New York
19. Harrington C.R., Roth M., Xuereb J.H., McKenna P.J., and Wischik C.M. Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci. Lett. 202 (1995) 101-104
20. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology, on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
21. Igata-Yi R., Igata T., Ishizuka K., Kimura T., Sakamoto S., and Katsuragi S. Apolipoprotein E genotype and psychosis. Biol. Psychiatry 41 (1997) 906-908
22. Jonsson E., Lannfelt L., Engvall B., and Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur. Arch. Psychiatry Clin. Neurosci. 246 (1996) 182-184
23. Joober R., Rouleau G., Fon E., Lal S., Palmour R., and Bloom D. Apolipoprotein E genotype in schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 67 (1996) 235
24. Kampman O., Anttila S., Illi A., Mattila K.M., Rontu R., and Leinonen E. Apolipoprotein E polymorphism is associated with age of onset in schizophrenia. J. Hum. Genet. 49 (2004) 355-359
25. Kimura T., Yokota S., Igata-Yi R., Shono M., Takamatsu J., and Miyakawa T. Apolipoprotein E epsilon2 allele and early onset schizophrenia. Neurosci. Lett. 231 (1997) 53-55
26. Kimura T., Yokota S., Shono M., Igata-Yi R., Takamatsu J., and Miyakawa T. Apolipoprotein E ε4 and schizophrenia. NeuroReport 8 (1997) 17
27. Kimura T., Shono M., Yokota S., Ishizuka K., Watanabe M., and Takamatsu J. Apolipoprotein E ε4 and tardive dyskinesia in a Japanese population. J. Psychiatr. Res. 34 (2000) 329-332
28. Kimura T., Shono M., Yokota S., Igata-Yi R., Takamatsu J., and Miyakawa T. Apolipoprotein E ε3 allele is not a risk factor of schizophrenia: a study of 314 Japanese patients. Neuropsychobiology 42 (2000) 66-68
29. Lan T.H., Hong C.J., Chen J.Y., and Sim C.B. Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol. Psychiatry 42 (1997) 225-227
30. Laws S.M., Taddei K., Martins G., Paton A., Fisher C., and Clarnette R. The -491AA polymorphism in the APOE gene is associated with increased plasma ApoE levels in Alzheimer's disease. NeuroReport 10 (1999) 879-882
31. Laws S.M., Hone E., Taddei K., Harper C., Dean B., and McClean C. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatry 7 (2002) 886-890
32. Lee M.K., Park A.J., Nam B.Y., Min K.J., Kee B.S., and Park D.B. Apolipoprotein E genotype in Korean schizophrenic patients. J. Korean Med. Sci. 16 (2001) 781-783
33. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., and Hovatta I. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part II. Schizophrenia. Am. J. Hum. Genet. 1 (2003) 34-48
34. Liu W.Q., Breen G., Zhang J.G., Li S., Gu N., Feng G.Y., and He L. Association of APOE gene with schizophrenia in Chinese, a possible risk factor in times of malnutrition. Schizophr. Res. 62 (2003) 225-230
35. 4 receptor gene and apolipoprotein E gene and schizophrenia. Chin. J. Psychiatry 36 (2003) 17-20
36. Mahadik S.P., and Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia. Schizophr. Res. 19 (1996) 1-17
37. Mahley R.W., and Rall Jr. S.C. Apolipoprotein E, far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. (2000) 507-537
38. Martorell L., Virgos C., Valero J., Coll G., Figuera L., and Joven J. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol. Psychiatry 6 (2001) 307-310
39. Middleton F.A., Pato C.N., Gentile K.L., McGann L., Brown A.M., Trauzzi M., Diab H., Morley C.P., Medeiros H., Macedo A., Azevedo M.H., and Pato M.T. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 1 (2005) 12-25
40. Pickar D., Malhotra A.K., Rooney W., Breier A., and Goldman D. Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 350 (1997) 930-931
41. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., and Helms M.J. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition. Neurology 48 (1997) 985-989
42. Ravelli G.P., Stein Z.A., and Susser M.W. Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 7 (1976) 349-353
43. Saiz P.A., Morales B., G-Portilla M.P., Alvarez V., Coto E., and Fernandez J.M. Apolipoprotein E genotype and schizophrenia, further negative evidence. Acta Psychiatr. Scand. 105 (2002) 71-75
44. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., and Goldfarb L. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 (1993) 710-711
45. Schurhoff F., Krebs M.O., Szake A., Loze J.Y., Goldberger C., and Quignon V. Apolipoprotein E in schizophrenia, a French association study and meta-analysis. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 119 (2003) 18-23
46. Soininen H.S., and Riekkinen P.J. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 6 (1996) 224-228
47. Song Y., Stampfer M.J., and Liu S.M. Meta-analysis, apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 2 (2004) 137-147
48. Sorbi S., Nacmias B., Tedde A., Latorraca S., Forleo P., and Guarnieri B.M. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci. Lett. 244 (1998) 118-120
49. St Clair D., Xu M.Q., Wang P., Yu Y.Q., Fang Y.R., and Zhang F. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 5 (2005) 557-562
50. Thibaut F., Coron B., Hannequin D., Segard L., Martin C., and Dollfus S. No association of apolipoprotein E epsilon 4 with schizophrenia even in cognitively impaired patients. Schizophr. Res. 30 (1998) 149-153
51. Thibaut F., Van der Elst A., Campion D., Martin C., Coron B., and Dollfus S. Apolipoprotein E-ε4 frequency in deficit schizophrenia. Eur. Psychiatr. 14 (1999) 148-151
52. Town T., Fallin D., Crawford F., Walsh S., Solomon R., and Mullan M. Lack of association between the apolipoprotein E ε4 allele (ApoE ε4) and chronic schizophrenia. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 74 (1997) 451-452
53. Woolf B. On estimating the relation between blood group and disease. Ann. Eugen. 19 (1955) 251-253
54. Zhang L.S. A study on the association between schizophrenia and APO E gene. Si Chuan Jing Shen Wei Sheng vol. 11 (1998) 233-235
55. Zhu S., Nothen M.M., Uhlhaas S., Rietschel M., Korner J., and Lanczik M. Apolipoprotein E genotype distribution in schizophrenia. Psychiatr. Genet. 6 (1996) 75-79